AbbVie Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
AbbVie Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2016 to 2023.
  • AbbVie Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $10.8B.
  • AbbVie Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$17.2B, a 30.6% increase from 2022.
  • AbbVie Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$24.8B, a 30.3% decline from 2021.
  • AbbVie Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$19B, a 65.5% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$17.2B +$7.58B +30.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-20
2022 -$24.8B -$5.76B -30.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-20
2021 -$19B -$7.54B -65.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
2020 -$11.5B -$30.2B -161% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-17
2019 $18.7B +$33.1B Jan 1, 2019 Dec 31, 2019 10-K 2022-02-18
2018 -$14.4B -$8.88B -161% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-19
2017 -$5.51B -$1.58B -40.3% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-21
2016 -$3.93B Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.